Abbott Laboratories is making some noise in the transcatheter aortic repair/implantation market this week by announcing CE mark of its Navitor system. The device is minimally invasive and for people with severe aortic stenosis who are at high or extreme surgical risk.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,